Business Wire
DrugDev CEO Ibraheem Mahmood Shortlisted for 2014 SCRIP Awards
Tuesday, 16 September 2014 04:05
Global change agent pushing far more medicines through development with modern technologies that enable clinical trial sponsors, CROs and investigators to do more clinical trials together
Read more...
 
Halloran Moves to Boston’s Innovation District, Announces Inc. Magazine Recognition As One of America’s Fastest-Growing Companies
Tuesday, 16 September 2014 04:05
Halloran moves to Boston’s Fort Point neighborhood and ranks on the 33rd annual Inc. 500|5000, a list of the
country’s fastest-growing private companies, with 78% growth
Read more...
 
Rexahn Pharmaceuticals to Present at the

Error. Page cannot be displayed. Please contact your service provider for more details. (19)

BioPharm America™ 2014 in Boston, Massachusetts, USA
Tuesday, 16 September 2014 04:05
The Trout Group LLCTricia Truehart, 646-378-2953 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Virology Publishes Genocea HSV-2 Antigen Discovery Paper
Tuesday, 16 September 2014 04:05
For media:Spectrum Science CommunicationsMegan Lustig, 202-955-6222 This e-mail address is being protected from spambots. You need JavaScript enabled to view it orFor investors:Genocea BiosciencesBob Farrell, 617-674-8261 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Zoetis Ranked Among Top Ten Companies for Working Mothers
Tuesday, 16 September 2014 03:10
Read more...
 
TapImmune Releases Positive Interim Data on Phase I Clinical Trial of Folate Receptor Alpha Antigens in Ovarian and Breast Cancer
Tuesday, 16 September 2014 03:10
All Patients Developed Immune Responses as All Five Peptides Shown to be Immunogenic
Read more...
 
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics (NASDAQ: TENX)
Tuesday, 16 September 2014 03:10
Read more...
 
Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock
Tuesday, 16 September 2014 03:10
Opexa Therapeutics, Inc.Karthik Radhakrishnan, 281-775-0600 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Surescripts Expands Electronic Prior Authorization Offering with Four PBMs and Six Health Technology Vendors
Tuesday, 16 September 2014 03:10
EHR-Integrated Solution Replaces Inefficient Manual Process, Drives Significant Time & Cost Savings for Prescribers, Pharmacists and Patients
Read more...
 
Walgreens Boots Alliance Files Form S-4 Registration Statement and Preliminary Proxy Statement/Prospectus Related to Walgreens Strategic Transaction with Alliance Boots
Tuesday, 16 September 2014 03:10
Read more...
 
Biotech Industry Investment Conference on Friday, September 26
  • Thermo Fisher Scientific Appoints New Members to Scientific Advisory Board
  • Alnylam Presents New Pre-Clinical Data with ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 in Development for the Treatment of Complement-Mediated Diseases
  • Lannett Voluntarily Conducts Internal Review in Response to Inquiry from Connecticut Attorney General Received in July 2014
  • Independent Living Systems Expands its Operation by Opening a New Office in Miami
  • Ophthotech Announces Fovista® Phase 2b Independent Analysis Shows that Fovista® Anti-PDGF Therapy, Combined with Anti-VEGF Therapy, is Associated with a Reduction of Sub-retinal Fibrosis in Wet AMD Patients
  • Novalis: Three Novalis Centers in the UK Certified to Meet a New Standard for Radiosurgery
  • << Start < Prev 4681 4682 4683 4684 4685 4686 4687 4688 4689 4690 Next > End >>

    Page 4685 of 5439
    BMR:1